| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Section of Endocrine Neoplasia and Hormonal Disorders, Department of Internal Medicine Specialties (J.P., G.X., S.-C.J.Y.), and Section of General Internal Medicine, Department of Internal Medicine Specialties (S.-C.J.Y.), University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Address all correspondence and requests for reprints to: S. Jim Yeung, M.D., Ph.D., University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 40, Houston, Texas 77030. E-mail: syeung{at}notes.mdacc.tmc.edu
Abstract
We previously demonstrated that the combination of a farnesyltransferase inhibitor, manumycin A, and paclitaxel had a synergistic antineoplastic effect on anaplastic thyroid cancer. In this study we investigated the apoptosis pathway involved. In ARO and KAT-4 cells, manumycin- plus paclitaxel-induced DNA fragmentation was blocked by the inhibitors of caspase-9, caspase-8, and caspase-3. The drug combination enhanced the activation of caspase-9, caspase-8, and caspase-3 and cytochrome c release into the cytosol. Cytochrome c release was not affected by the inhibitors of caspase-9, caspase-8 and caspase-3. In a cell-free reconstitution assay, DNA fragmentation occurred after incubating nuclei purified from untreated KAT-4 cells with deoxy-ATP, exogenous cytochrome c and S-100 extracts from control KAT-4 cells, and also after incubation of purified KAT-4 nuclei with S-100 extracts from KAT-4 cells treated with manumycin-plus-paclitaxel. In both cases, the DNA fragmentation was blocked by the inhibitors of caspase-9, caspase-8 and caspase-3. We concluded that the cytochrome c release was upstream of the activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells treated with manumycin plus paclitaxel, and that the interaction between manumycin and paclitaxel occurred at or upstream of cytochrome c in the apoptosis regulatory pathway in anaplastic thyroid cancer cells.
This article has been cited by other articles:
![]() |
J. Pan, A. Quintas-Cardama, H. M. Kantarjian, C. Akin, T. Manshouri, P. Lamb, J. E. Cortes, A. Tefferi, F. J. Giles, and S. Verstovsek EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation Blood, January 1, 2007; 109(1): 315 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Are and A. R. Shaha Anaplastic Thyroid Carcinoma: Biology, Pathogenesis, Prognostic Factors, and Treatment Approaches Ann. Surg. Oncol., April 1, 2006; 13(4): 453 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Choi, M.-J. Kim, C.-M. Kang, S. Bae, C.-K. Cho, J.-W. Soh, J.-H. Kim, S. Kang, H. Y. Chung, Y.-S. Lee, et al. Activation of Bak and Bax through c-Abl-Protein Kinase C{delta}-p38 MAPK Signaling in Response to Ionizing Radiation in Human Non-small Cell Lung Cancer Cells J. Biol. Chem., March 17, 2006; 281(11): 7049 - 7059. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Bravo, M. E.R. Garcia-Rendueles, R. Seoane, V. Dosil, J. Cameselle-Teijeiro, L. Lopez-Lazaro, J. Zalvide, F. Barreiro, C. M. Pombo, and C. V. Alvarez Plitidepsin Has a Cytostatic Effect in Human Undifferentiated (Anaplastic) Thyroid Carcinoma Clin. Cancer Res., November 1, 2005; 11(21): 7664 - 7673. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pan, H. Huang, L. Sun, B. Fang, and S.-C. J. Yeung Bcl-2-Associated X Protein Is the Main Mediator of Manumycin A-Induced Apoptosis in Anaplastic Thyroid Cancer Cells J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3583 - 3591. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pan, M. She, Z.-X. Xu, L. Sun, and S.-C. J. Yeung Farnesyltransferase Inhibitors Induce DNA Damage via Reactive Oxygen Species in Human Cancer Cells Cancer Res., May 1, 2005; 65(9): 3671 - 3681. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cozzolino, P. Palladino, F. Rossi, G. Cali, E. Benedetti, and P. Laccetti Antineoplastic cyclic astin analogues kill tumour cells via caspase-mediated induction of apoptosis Carcinogenesis, April 1, 2005; 26(4): 733 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-B. Zhong, C.-Y. Wang, T.-C. Chang, and W.-S. Lee Lovastatin Induces Apoptosis of Anaplastic Thyroid Cancer Cells via Inhibition of Protein Geranylgeranylation and de Novo Protein Synthesis Endocrinology, September 1, 2003; 144(9): 3852 - 3859. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kossmehl, M. Shakibaei, A. Cogoli, M. Infanger, F. Curcio, J. Schonberger, C. Eilles, J. Bauer, H. Pickenhahn, G. Schulze-Tanzil, et al. Weightlessness Induced Apoptosis in Normal Thyroid Cells and Papillary Thyroid Carcinoma Cells via Extrinsic and Intrinsic Pathways Endocrinology, September 1, 2003; 144(9): 4172 - 4179. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Yang, J.-X. Pan, L. Sun, and S.-C. J. Yeung p21 Waf-1 (Cip-1) Enhances Apoptosis Induced by Manumycin and Paclitaxel in Anaplastic Thyroid Cancer Cells J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 763 - 772. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |